🔗 Visit the ClinicalTrials.gov page for NCT00995007
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Pathway inhibition: emerging molecular targets for treating glioblastoma. | Neuro Oncol | 2011 | 1.38 |
| 2 | Experimental approaches for the treatment of malignant gliomas. | Pharmacol Ther | 2010 | 1.23 |
| 3 | A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma. | Neuro Oncol | 2003 | 1.15 |
| 4 | Unique biology of gliomas: challenges and opportunities. | Trends Neurosci | 2012 | 0.87 |
| 5 | Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial. | Am J Clin Oncol | 1996 | 0.85 |
| 6 | Current status and future directions of anti-angiogenic therapy for gliomas. | Neuro Oncol | 2015 | 0.77 |